NuScale Power Stock Is Cheap, but Does That Make It a Buy Now?

NuScale Power is down 75% from its 52-week high, and the company still has not secured its first customer for a small modular reactor sale. While it has a regulatory-approved SMR design and has placed early orders for parts for up to 12 reactors, the article stresses that the technology remains unproven until an actual sale closes. Government support for SMRs is a positive, but the piece argues the stock remains a risky, speculative hold for most investors.

Analysis

SMR is being priced like a commercialization story, but the market is still assigning close to zero value to conversion from design approval to repeatable execution. The real issue is not technology risk in the abstract; it is customer adoption risk in a capital-intensive industry where buyers need certainty on cost, build schedule, and financing before signing. That means the stock can stay depressed for months even if the technology remains directionally attractive, because the catalyst path is binary and long-dated.

The second-order effect is that any first deal will matter far more than the headline size of that deal. A single credible customer would likely re-rate the name sharply because it validates the procurement process, de-risks supply chain access, and signals that lead times can convert into backlog rather than inventory risk. Conversely, another delay would pressure not just SMR but the broader SMR ecosystem, including suppliers and adjacent “nuclear optionality” names, because investors will start discounting the whole category as science-project exposure rather than industrial adoption.

The most interesting asymmetry is that the current drawdown may be justified fundamentally, but the market could still be underpricing how fast sentiment can flip on one contract announcement. This is a classic long-duration catalyst setup: low probability near term, high convexity if it lands. The problem is financing dilution and execution slippage in the meantime, which can cap any rally unless order flow is visible and accompanied by credible project economics.

For the broader market, the article is a reminder that AI-driven power demand does not automatically translate into winners; the bottleneck is deployment-ready generation, not just demand growth. If SMR commercialization stalls, capital may rotate toward established power infrastructure, grid equipment, and uranium-linked names with nearer-term monetization. In that scenario, SMR becomes a sentiment trade rather than a fundamentals trade.

Key Decisions for Investors

• Stay out of SMR ahead of a confirmed first customer; use the next 1-3 months as a catalyst watch period rather than trying to catch the falling knife. Risk/reward remains poor until there is signed backlog or binding project financing.
• If you want optionality, buy a small-sized SMR call spread 6-12 months out only on a contract announcement; structure it as a convex event trade because upside can be sharp, but time decay is punitive without a catalyst.
• Pair trade: short SMR vs long an established beneficiary of power-capex spending (e.g., NEE or an industrial grid supplier if liquidity is preferred). The idea is to own monetization certainty while fading pre-revenue hype.
• Watch for dilution or financing terms over the next several quarters; if the company needs to bridge working capital before commercialization, that is a better short trigger than valuation alone.
• If a first sale is announced, take profits quickly into the initial rerating; the likely move is sentiment-driven and may outrun the underlying economics before delivery risk is actually resolved.